Interleukin‐22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer

Interleukin (IL)‐22 is recognized as a tumor‐supporting cytokine and is implicated in the proliferation of multiple epithelial cancers. In breast cancer, the current knowledge of IL‐22 function is based on cell line models and little is known about how IL‐22 affects the tumor initiation, proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Katara, Gajendra K., Kulshrestha, Arpita, Schneiderman, Sylvia, Riehl, Valerie, Ibrahim, Safaa, Beaman, Kenneth D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944104/
https://www.ncbi.nlm.nih.gov/pubmed/31725949
http://dx.doi.org/10.1002/1878-0261.12598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944104/
https://www.ncbi.nlm.nih.gov/pubmed/31725949
http://dx.doi.org/10.1002/1878-0261.12598

Ejemplares similares